Summary:
Help
Develop the Next Life-Saving Vaccine—Volunteer Now
- The purpose of this trial
is to see how your immune system (your body’s natural defense that fights off
germs and keeps you healthy) reacts to an investigational vaccine against Sudan
virus disease.
- In
humans, Sudan Ebolavirus (SUDV) is responsible for causing Sudan Virus Disease
(SVD), formerly known as Ebola hemorrhagic fever. It spreads through
human-to-human transmission, with infection resulting from direct contact with
blood, secretions, organs, or other bodily fluids of infected people, and
indirect contact with contaminated environments. The average case fatality rate
of SVD is around 50%.
- As there are currently no
approved vaccines or therapeutics to treat individuals infected with SUDV, a
vaccine with rapid and durable protective immunity would be desirable for
populations in areas of the world where outbreaks occur sporadically
Qualified Participants Must:
• Healthy Adults
•
Be 18 to 70 years old
•
Health status is further evaluated by reviewing medical history, screening assessments, and visit with physician
•
Be available and willing to commit to the trial visit structure - You will be asked to come to our clinic for 8 outpatient visits and 2 follow-up phone calls.
Qualified Participants May Receive:
Eligible
participants will receive trial related care and assessments at no cost and may
be compensated up to $1,250 for trial related time.